Mo1111 RNASET2 RISK VARIANT AS A NOVEL BLOOD BASED DIAGNOSTIC FOR DEFINING A SEVERE CD PATIENT POPULATION RESPONSIVE TO DIRECTED RNASET2 THERAPEUTICS

Autor:	Rivkah Gonsky, Stephan R. Targan, Eva Biener-Ramanujan, Dermot P.B. McGovern, Janine Bilsborough, Ignat. Printsev, Frank Kim
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Patient population Risk variant Hepatology business.industry Internal medicine Gastroenterology medicine business
Zdroj:	Gastroenterology. 158:S-791
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(20)32652-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e1e11a65e8ec155e2a79387b4e9b7c41 https://doi.org/10.1016/s0016-5085(20)32652-4 Zobrazit plný text záznamu